tradingkey.logo
tradingkey.logo
Search

Globus Medical Inc

GMED
Add to Watchlist
74.690USD
-1.080-1.43%
Close 09-14 16:00ET
10.02BMarket Cap
17.19P/E TTM
After-hours 16:10 (ET)74.690USD+0.100+0.13%

Globus Medical Inc (GMED) Revenue Performance

Updated: Jun 30, 2026

Last year, Globus Medical Inc generated 2.80B USD for its biggest-performing segment, Musculoskeletal Solutions. The United States made the largest contribution, accounting for 2.37B USD last year. For the latest quarter, Globus Medical Inc reported the revenue of 763.54M USD for the period ending 2026-06-30, which came from the top-performing segment, Musculoskeletal Solutions. United States contributed the highest revenue, at 619.11M USD.

By Business

Annual
Annual
Quarterly
Musculoskeletal Solutions
Enabling Technologies
Musculoskeletal Solutions
Musculoskeletal Solutions products
Enabling Technologies
Enabling Technologies products
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
Musculoskeletal Solutions
2.80B(95.20%)
--(--)
--(--)
--(--)
--(--)
--(--)
--(--)
--(--)
Enabling Technologies
141.01M(4.80%)
--(--)
--(--)
--(--)
--(--)
--(--)
--(--)
--(--)
Musculoskeletal Solutions
--(--)
2.37B(46.94%)
1.45B(46.17%)
--(--)
--(--)
--(--)
--(--)
--(--)
Musculoskeletal Solutions products
--(--)
2.37B(46.94%)
1.45B(46.17%)
926.70M(90.60%)
876.78M(91.51%)
748.45M(94.86%)
738.38M(94.02%)
666.04M(93.42%)
Enabling Technologies
--(--)
154.00M(3.06%)
120.22M(3.83%)
--(--)
--(--)
--(--)
--(--)
--(--)
Enabling Technologies products
--(--)
154.00M(3.06%)
120.22M(3.83%)
96.14M(9.40%)
81.32M(8.49%)
40.60M(5.14%)
46.99M(5.98%)
46.93M(6.58%)

By Region

Annual
Annual
Quarterly
United States
International
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
United States
2.37B(80.56%)
2.00B(79.39%)
1.28B(81.59%)
871.94M(85.25%)
819.57M(85.54%)
664.45M(84.21%)
647.68M(82.47%)
593.88M(83.30%)
International
571.34M(19.44%)
519.29M(20.61%)
288.71M(18.41%)
150.90M(14.75%)
138.53M(14.46%)
124.59M(15.79%)
137.69M(17.53%)
119.09M(16.70%)
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.